SPOTLIGHT IN FOCUS – The Rise of Psychedelic Therapy
Dr. Zinia Thomas at Radiance Wellness, St. Louis MO –…
Psychedelic Spotlight News
How Psychedelics Helped GoDaddy Founder Bob Parsons Treat His PTSD
Bob Parsons is an American entrepreneur and a Marine Corps…
Encountering DMT Entities: Are they Real?
DMT is a powerful hallucinogen famous for producing experiences of encounters with entities, but how many people actually see them?
Sol Psychedelphia – A Psychedelics Community Education Event
“This event wisely explores and intentionally focuses on living better through evidence-based science and the potential that plant and entheogenic substances have for transformative healthcare”, Mia Lowry, Director of Outreach.
Psychedelic Business Spotlight – June 10
This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed’s stock is removed from an index; and more!
Consolidating Plant Medicine, Permaculture and Indigenous Wisdom With Colette Condorcita, Decriminalize Philadelphia
In this episode, Colette describes her diverse background working closely with plant medicines and Indigenous groups in South America, how psychedelics are intrinsically aligned with permaculture and the cultivation of sacred plants, and much more.
Can Psychedelics Improve Scientific Creativity?
Scientific discovery comes from creative insights, and a recently published review details how psychedelics can play a major role in scientific creativity.
The History of LSD: A Story of Self-Experimentation
Despite the LSD experience lasting only two hours, Hofmann was amazed at the power of his creation. And like any good scientist, he knew exactly what he had to do: self-experiment.
Canada’s Ready for Psychedelic Therapy – CATALYST SUMMIT 2022
The Catalyst Summit 2022 reunited politicians, mycologists, doctors, psychotherapists and…
Psychedelic Business Spotlight – June 3
This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on treating depression with psilocybin; Clearmind files for a new patent; and much more!
End of content
End of content